Resveratrol






5526 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 2512929 In vitro inhibition of mouse hepatic mixed-function oxidase enzymes by helenalin and alantolactone. Biochem Pharmacol 1989 Nov 15 3
2 3038751 Influence of type and opsonization of ingested particle on intracellular free calcium distribution and superoxide production by human neutrophils. Infect Immun 1987 Aug 1
3 3922423 Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985 Apr 25 2
4 7554275 The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995 Mar 31 1
5 7664473 Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta 1995 Jun 15 1
6 9391166 Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 1997 Dec 9 3
7 9581680 Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 1998 May 3
8 9586953 Interaction of transresveratrol with plasma lipoproteins. Biochem Pharmacol 1998 Mar 15 1
9 9605577 Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998 Apr 6
10 9680369 Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998 Aug 1 6
11 9705326 Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998 Aug 21 8
12 9785383 Paradoxical effects of resveratrol on the two prostaglandin H synthases. Prostaglandins Other Lipid Mediat 1998 Jun 6
13 9846848 Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 1998 Dec 11
14 9865727 Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 1998 Dec 15 13
15 9886234 Lectin-mediated drug targeting: quantification of binding and internalization of Wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. J Drug Target 1998 1
16 9974427 Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol 1999 Feb 12
17 10069459 Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999 Feb 8
18 10188978 Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999 Feb 5
19 10228948 Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells. J Cell Physiol 1999 Jun 2
20 10232077 Anti-allergic action of resveratrol and related hydroxystilbenes. Planta Med 1999 Apr 2
21 10320034 Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci Lett 1999 Apr 2 12
22 10328958 Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp Cell Res 1999 May 25 5
23 10356984 Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett 1999 May 14 12
24 10363980 Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res 1999 Jun 1 3
25 10370867 Cancer chemopreventive activity of resveratrol. Drugs Exp Clin Res 1999 12
26 10370870 Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant? Drugs Exp Clin Res 1999 3
27 10374244 Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine 1999 May 4
28 10381133 Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett 1998 Dec 11 2
29 10402233 Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int J Oncol 1999 Aug 3
30 10403535 Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 1999 Jun 1 1
31 10448061 Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 1999 Aug 19 1
32 10491155 Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. Eur J Biochem 1999 Oct 1 4
33 10492890 Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc Repub China B 1999 Jul 5
34 10496959 Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 1999 Oct 10
35 10496962 Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999 Oct 6
36 10498846 trans-Resveratrol inhibits calcium influx in thrombin-stimulated human platelets. Br J Pharmacol 1999 Sep 5
37 10563851 PH-dependent forms of red wine anthocyanins as antioxidants. J Agric Food Chem 1999 Jan 1
38 10600179 The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C alpha activity. Arch Biochem Biophys 1999 Dec 15 3
39 10606230 Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res 1999 Dec 1 4
40 10668496 Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Ann N Y Acad Sci 1999 5
41 10698352 Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000 Jan 21 1
42 10718345 Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000 Apr 1 3
43 10769659 Grape-derived chemopreventive agent resveratrol decreases prostate-specific antigen (PSA) expression in LNCaP cells by an androgen receptor (AR)-independent mechanism. Anticancer Res 2000 Jan-Feb 6
44 10775377 Separation of biologically active lipids from red wine. J Agric Food Chem 2000 Apr 1
45 10783318 Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 2000 May 2
46 10824865 Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol 1999 2
47 10837497 Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J Biol Chem 2000 Jun 9 2
48 10843709 Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000 Jun 15 11
49 10848832 Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br J Haematol 2000 May 14
50 10854714 Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines. Mol Cell Endocrinol 2000 Apr 25 2